Assessment of Ultrsound-facilitated Neurotherapeutics in Alzheimer's Disease
Description: PUBLIC HEALTH RELEVANCE: One of the primordial reasons why Alzheimer's remains undertreated is that current treatments of neurological and neurodegenerative diseases are limited due to the lack of a truly noninvasive, transient, and regionally selective brain drug delivery method. For the purpose of this study, we will apply FUS for the effective treatment of Alzheimer's disease and employ gene delivery due to its great promise and associated low blood-brain barrier impermeability.
Funder: National Institute on Aging
Funding type: research
Funder scheme: R01
Start date: 2011-08-01
End date: 2023-02-28
Investigator: ELISA E. KONOFAGOU
Institution: COLUMBIA UNIVERSITY HEALTH SCIENCES
Funded outputs count: 85
Funder award ID: R01AG038961
OpenAlex ID: G4140398457